US Food and Drug Administration Review Time of Supplemental New Indication Approvals of Drugs and Biologics, 2017 to 2019.

ABSTRACT:

SUBMITTER: Dhodapkar MM 

PROVIDER: S-EPMC10293905 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature